Henry Ji - 02 Sep 2022 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role
President, CEO and Chairman of the Board of Directors, Director
Signature
/s/ Henry Ji, Ph.D.
Issuer symbol
N/A
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
4
Filing time
02 Sep 2022, 16:31:50 UTC
Previous filing
26 Aug 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Award $0 +2,500,000 +118% $0.000000 4,621,362 02 Sep 2022 Direct F1
holding SRNEQ Common Stock 2,271,693 02 Sep 2022 See Footnote F2
holding SRNEQ Common Stock 40,000 02 Sep 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/4th of which shall vest on September 2, 2023 and 1/4th of which shall vest on each anniversary thereafter.
F2 Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Remarks:

President, CEO and Chairman of the Board of Directors